Endothelial Function in Children with Acute Lymphoblastic Leukemia (ALL) May Reflect the Clinical Outcome

Figure 3

1. day, 33. day, M (the protocol M beginning day)—points of evaluation in the study group. (a) Endothelial activation and systemic inflammation markers in children with ALL at particular steps of the study protocol and in the control group. (b) Analysis of endothelial activation and systemic inflammation markers in children with ALL assigned to the subgroups separated according to the risk stratification. (c) Analysis of endothelial activation and systemic inflammation markers in children with ALL assigned to the subgroups separated according to the short-term survival.

(a)

(b)

(c)